Betsmove Platformuna Genel Bakış ve Erişim Rehberi

Bu sayfa, Betsmove ile ilgilenen kullanıcılar için hazırlanmıştır. Platforma nasıl giriş yapılır, kullanıcılar hangi bilgilere ihtiyaç duyar gibi konular anlaşılır ve sade bir şekilde açıklanmıştır.

Betsmove Hakkında Temel Bilgiler

Betsmove, kullanıcılarına çevrimiçi bahis ve spor içerikleri sunan bir platformdur. Bu sayfa, platformun işleyişi, kullanıcıların dikkat etmesi gereken noktalar ve genel bilgiler hakkında rehberlik sağlar. Kısa ve tekrarsız bir içerik ile bilgilenmek isteyenler için hazırlanmıştır.

Giriş İşlemleri ve Arama İhtiyacı

Kullanıcılar, Betsmove’a erişim sağlamak ve güncel bağlantı bilgilerini öğrenmek için sıkça giriş aramaları yapar. Ayrıca platformun sunduğu hizmetler ve özellikler hakkında fikir edinmek isteyenler bu sayfalara yönelir. Bu tür içerikler, arama motorları tarafından değerli olarak değerlendirilir.

Bilgilendirme ve Rehberlik Amacı

Sayfamızın amacı, ziyaretçileri yönlendirmek veya platforma yönlendirmek değil, yalnızca bilgi vermektir. Betsmove hakkında doğru ve güncel bilgilere kolayca ulaşabilmeniz için hazırlanmış bir rehber niteliğindedir.

Drugs (Fifth Amendment) Rules, 2024 notified - 1-Comply

Drugs (Fifth Amendment) Rules, 2024 notified

Notification No: G.S.R. 669(E)

Notification Date:  28th October, 2024

Effective Date:  29th October, 2024

Relevant Act/Rule:  Drugs and Cosmetics Act, 1940, Drugs Rules, 1945
The Ministry of Ayush has notified  the Drugs (Fifth Amendment) Rules, 2024 on October 28, 2024. The said Rules would come into force from 29th October, 2024, viz. the date of publication in the Official Gazette. The said Rules have introduced changes to the licensing and manufacturing processes for Ayurveda, Siddha, Sowa-Rigpa, Unani, Homeopathic medicines in India.
 
Some of the key changes introduced vide said amendment are as follows:
 
New Homeopathic Medicines defined: 
 
These Rules have also  defined “New Homeopathic Medicines” and established a clear process for their importation and approval. They require comprehensive evidence of safety, therapeutic efficacy, and minimum homoeopathic provings for any new medicines. A product will be considered “new” for a period of five years following its initial approval.  After completion of five years, these medicines will be considered as homoeopathy medicines defined under rule 2 (dd).
 
*Online applications through the e-AUSHADHI portal:
 
  The rules introduced an online application system via the e-AUSHADHI portal, making it easier to apply for licenses to sell, stock, and distribute homeopathic medicines. License application fees have been standardized. Retail and wholesale licenses for homeopathic medicines will now be perpetual, with a self-declaration of compliance to regulations required every five years. as per new Rule 67E.
 
*Good Manufacturing Practices (GMP) certificate:
 
  The regulations mandate that manufacturers obtain a Good Manufacturing Practices (GMP) certificate to secure a manufacturing license.  
 
*Quality Control:
 

The rules also define the qualifications necessary for personnel supervising the production of homeopathic medicines. Regular inspections of manufacturing facilities will be conducted at least once every five years. Additionally, GMP certificates will be valid indefinitely, subject to a renewal fee every five years. The new rules also provide for greater transparency by allowing online access to license applications and, where applicable, details of manufactured medicines, assuming online records are maintained.

These regulations aim to enhance the quality, safety, and availability of homeopathic medicines in India. The introduction of an online application system and perpetual licenses should simplify the licensing process for legitimate manufacturers and sellers. With an emphasis on new medicines and stricter quality control measures, the regulations seek to ensure that homeopathic products meet high standards of efficacy and safety.

Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article. 

To stay updated Subscribe to our newsletter today

Explore other Legal updates on the 1-Comply and follow us on LinkedIn to stay updated 

Post Views: 237

Schedule A Demo